Feixia Shen
- Molecular Biology
- Endocrinology, Diabetes and Metabolism
- Epidemiology
- Pharmacology top 10%
- Cancer Research
- Topics
- Angiogenesis and VEGF in Cancer (4 papers)MicroRNA in disease regulation (3 papers)Pharmacological Effects of Natural Compounds (3 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Feixia Shen
18 papers receiving 408 citations
Peers
Comparison fields: 5 of 87
- Molecular Biology 200
- Endocrinology, Diabetes and Metabolism 79
- Epidemiology 67
- Pharmacology 65
- Cancer Research 62
Countries citing papers authored by Feixia Shen
This map shows the geographic impact of Feixia Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feixia Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feixia Shen more than expected).
Fields of papers citing papers by Feixia Shen
This network shows the impact of papers produced by Feixia Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feixia Shen. The network helps show where Feixia Shen may publish in the future.
Co-authorship network of co-authors of Feixia Shen
This figure shows the co-authorship network connecting the top 25 collaborators of Feixia Shen. A scholar is included among the top collaborators of Feixia Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feixia Shen. Feixia Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 16 | |
| 3 | 4 | |
| 4 | 81 | |
| 5 | 43 | |
| 6 | 24 | |
| 7 | 1 | |
| 8 | 2 | |
| 9 | 13 | |
| 10 | 8 | |
| 11 | 13 | |
| 12 | 41 | |
| 13 | 34 | |
| 14 | 52 | |
| 15 | 55 | |
| 16 | 24 | |
| 17 | 2 | |
| 18 | 1 |
About Feixia Shen
Feixia Shen is a scholar working on Pharmacology, Cancer Research and Endocrinology, Diabetes and Metabolism, having authored 18 papers that have together received 415 indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (4 papers), MicroRNA in disease regulation (3 papers) and Pharmacological Effects of Natural Compounds (3 papers). The work is most often cited by research in Pharmacology (65 citations), Endocrinology, Diabetes and Metabolism (79 citations) and Geriatrics and Gerontology (17 citations). Feixia Shen has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Xiong Chen, Xuemei Gu, Rongrong Le, Zimiao Chen, Xiaoqing Yan, Guangliang Hong, Ke Xu, Xiaozhong Huang, Yujuan Shi and Hongjin Chen. Their work appears in journals such as Diabetes, Biochemical and Biophysical Research Communications and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.